A Prospective Double-Blind Placebo Controlled Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

dc.contributor
Universitat Internacional de Catalunya. Departament de Medicina
dc.contributor.author
Rubina Filipa Ascensão, Alves
dc.date.accessioned
2017-05-25T17:42:38Z
dc.date.available
2017-05-25T17:42:38Z
dc.date.issued
2017-02-17
dc.identifier.uri
http://hdl.handle.net/10803/403440
dc.description.abstract
Background: Androgenetic Alopecia (AGA) is a nonscarring alopecia that affects both men and women. It is characterized by a progressive miniaturization of hair follicles with a characteristic pattern distribution in genetically predisposed men and women. The currently available treatments for AGA are sometimes perceived as having limited effectiveness, therefore, Platelet-rich plasma (PRP) has been postulated as a new therapy for AGA. Objective: To assess the efficacy of PRP on the evolution of AGA, between 6 months of treatment and baseline. Methods: This was a prospective, randomized, placebo controlled, double-blind, half-head study in male and female patients with AGA. The patient selection was performed in two different phases, according to presence or absence of medication for AGA. Group A included patients without previous medication for AGA and Group B included patients under medication for AGA (minoxidil or finasteride). All patients received a total of 3 treatments of PRP on one half-head and saline solution in the other half-head, with an interval of 1 month from each other. Injected areas comprised 4 circular areas marked with a dot tattoo. The follow-up visit was made at 6 months. Results: In Group A: administration of PRP alone attended a statistically significant improvement of mean hair density, mean terminal hair density, mean anagen hairs and telogen hairs, when compared with baseline, at 6 months. A statistically significantly correlation between demographic data and trichoscan analysis was found with two parameters: mean total hair density and mean anagen hairs. Regarding Group B: administration of PRP associated with ongoing medication is effective on the evolution of AGA. Both minoxidil or finasteride associated with PRP improved hair regrowth, although PRP in combination with minoxidil showed a greater improvement than PRP with finasteride, at six months. Limitations: The two major limitations of this study relate to the sample size and duration of follow-up. Conclusion: Administration of autologous PRP had a positive effect on male and female pattern hair loss without major side-effects.
en_US
dc.format.extent
258 p.
en_US
dc.format.mimetype
application/pdf
dc.language.iso
eng
en_US
dc.publisher
Universitat Internacional de Catalunya
dc.rights.license
L'accés als continguts d'aquesta tesi queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons: http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.uri
http://creativecommons.org/licenses/by-nc-nd/4.0/
*
dc.source
TDX (Tesis Doctorals en Xarxa)
dc.subject
Alopecia
en_US
dc.subject
Androgenetic alopecia
en_US
dc.subject
Hair loss
en_US
dc.subject
Platelet-rich plasma
en_US
dc.subject
Growth factors
en_US
dc.subject
Double-blind
en_US
dc.subject
Clinical trial
en_US
dc.subject
Drug therapy
en_US
dc.subject
Humans
en_US
dc.subject.other
Dermatología
en_US
dc.title
A Prospective Double-Blind Placebo Controlled Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia
en_US
dc.type
info:eu-repo/semantics/doctoralThesis
dc.type
info:eu-repo/semantics/publishedVersion
dc.subject.udc
616.5
en_US
dc.contributor.authoremail
rubinaalves@gmail.com
en_US
dc.contributor.director
Grimalt, Ramon
dc.embargo.terms
cap
en_US
dc.rights.accessLevel
info:eu-repo/semantics/openAccess


Documents

Tesi Rubina Filipa Alves.pdf

26.92Mb PDF

Aquest element apareix en la col·lecció o col·leccions següent(s)